Japanese Targeted Collagen — Scientific Dossier
INGREDIENT DOSSIER
Japanese Targeted Collagen™ Scientific Dossier
Human clinical evidence supporting bioactive fish collagen peptides — Pro-Hyp and Hyp-Gly enriched — for skin hydration, elasticity, and healthy aging.
Skin aging & the extracellular matrix
Visible aging starts beneath the surface, in the structural scaffold that holds skin together.
The dermal extracellular matrix — collagen fibers, elastin, glycosaminoglycans, hyaluronic acid, proteoglycans, and the fibroblasts that maintain them — degrades progressively with age, and that decline shows up directly as wrinkles, reduced elasticity, impaired hydration, and increased roughness.
Reduced synthesis
Fibroblast collagen production slows, while breakdown continues at the same pace or accelerates.
Hydration loss
Declining hyaluronic acid and glycosaminoglycan content reduces the skin's capacity to retain water.
Glycation stiffening
Advanced glycation end products cross-link collagen fibers, making tissue stiffer and less resilient.
Cumulative photoaging
UV exposure compounds structural damage over time, adding pigmentation and roughness on top of intrinsic aging.
Why bioactive peptides, not just collagen
For decades, collagen supplements were assumed to work as a simple amino acid source. That view no longer holds up.
Human pharmacokinetic research has shown that collagen hydrolysates generate specific dipeptides — prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly) — that survive gastrointestinal digestion intact and remain detectable in human plasma, rather than being broken down to individual amino acids like most dietary protein.
Pro-Hyp
- Stimulates fibroblast chemotaxis
- Promotes fibroblast proliferation
- Increases hyaluronic acid synthesis
- Supports extracellular matrix remodeling
Hyp-Gly
- Supports extracellular matrix structure
- Contributes to dermal structural maintenance
- Supports connective tissue remodeling
- Helps maintain skin elasticity
Why this collagen peptide
Not all collagen is manufactured — or studied — the same way.
Nitta Gelatin — Wellnex® collagen peptides
Japanese Targeted Collagen™ uses fish-derived collagen peptides from Nitta Gelatin Inc., a Japanese ingredient manufacturer with more than a century in the collagen industry. Nitta Gelatin's research division was the first to identify Pro-Hyp and Hyp-Gly as intact, bioavailable dipeptides within the collagen molecule — the discovery that reframed collagen supplementation around peptide composition rather than protein quantity alone.
Every human trial in this dossier was conducted using this specific fish-collagen technology, developed and supplied by Nitta Gelatin's Peptide Division in Osaka, Japan — not a generic or unspecified collagen source.
What the human trials show
Five randomized, double-blind, placebo-controlled human trials, covering hydration, elasticity, wrinkles, pigmentation, and glycation outcomes.
AFacial hydration & elasticity
The two foundational trials both measured hydration and elasticity directly — and the second was designed specifically to test whether peptide composition, not just collagen dose, drives the effect.
Facial hydration, elasticity & roughness
Cheek elasticity improved +5.79% and periocular elasticity +8.88%, with a significant reduction in skin roughness. Benefits were largely retained two weeks after stopping supplementation. *Corneometer units, baseline → week 8 — see note on percentage reporting in References.
Composition beats quantity
Tested a high-bioactive-peptide collagen against a conventional, lower-peptide collagen at the same dose. The high Pro-Hyp/Hyp-Gly formula significantly outperformed on hydration, elasticity, wrinkle depth and area, and texture — clinical efficacy tracked peptide concentration, not collagen amount.
BWrinkles & photoaging
Two further trials moved from general skin quality into two specific, visible signs of aging: periorbital wrinkles and UV-induced pigmentation.
Periorbital wrinkles & condition
Significant reductions in periorbital wrinkles versus placebo, alongside highly significant increases in hydration and elasticity and improved overall appearance scores. No adverse events reported.
UV-induced pigmented spots
Significant reductions in UV spot area, visible from 4 weeks and sustained at 8. The authors themselves labelled this a preliminary study — worth keeping that framing rather than upgrading its weight.
CGlycation & metabolic aging
The newest trial in this evidence base looks past the surface, at how collagen peptides interact with glycation — a slower, structural driver of skin stiffening.
Advanced glycation end products (AGEs)
Significant reductions in skin AGE accumulation versus placebo, with a correlated improvement in HOMA-IR (an insulin-sensitivity marker). Framed here as a metabolic-aging signal, not a metabolic-health treatment claim — the population was healthy adults, not a diabetes or prediabetes cohort.
Endpoint-by-endpoint summary
Recomputed directly from the 5 peer-reviewed trials above — see the note below on why this differs slightly from a manufacturer round-up.
| Clinical endpoint | Studies | Outcome |
|---|---|---|
| Skin hydration | 3 | Positive |
| Skin elasticity | 3 | Positive |
| Wrinkle reduction | 2 | Positive |
| Skin roughness / texture | 2 | Positive |
| UV pigmentation | 1 (preliminary) | Positive |
| Glycation (AGEs) reduction | 1 | Positive |
| Insulin sensitivity marker (HOMA-IR) | 1 | Positive |
| Safety | 5 of 5 | No serious adverse events |
How bioactive peptides act on skin
Both dipeptides converge on the dermal fibroblast — the cell responsible for producing and maintaining the extracellular matrix — but through distinguishable routes.
Fibroblast signaling (Pro-Hyp)
- Chemotaxis draws fibroblasts toward areas of matrix turnover
- Enhanced proliferation increases the fibroblast population available for repair
- Upregulated hyaluronic acid synthesis supports hydration from within the dermis
Structural maintenance (Hyp-Gly)
- Supports the structural integrity of the collagen network itself
- Contributes to connective tissue remodeling alongside Pro-Hyp
- Associated with elasticity maintenance in the trials above
From research dose to product dose
The trials above used doses of 2.5 g to 5 g per day of a peptide-optimized fish collagen — not an arbitrary "collagen" serving size, but a specific concentration of Pro-Hyp and Hyp-Gly reached at those amounts.
Two things worth confirming before this goes live
Per-serving dose: does a daily serving of Japanese Targeted Collagen™ deliver [insert per-serving collagen peptide dose] g, comparable to the 2.5–5 g/day studied range? That comparison is the single most useful credibility signal on the page.
Study count: the source dossier this was built from listed a sixth item — "Wellnex® Bioactive Dipeptide Technology" — as a separate study. It isn't one: it's Nitta Gelatin's own technical summary of the same five trials above, without its own population, dose, or duration. I've left it out of the study count and evidence-synthesis table accordingly (5 studies, not 6) rather than double-counting the underlying research. Worth knowing in case that "6 studies" figure appears anywhere else in your materials.
Hydration percentages: the source material's hydration table computed "% change" as (new value − old value) ÷ new value, not the conventional ÷ old value — so the raw Corneometer numbers in the cards above are accurate, but I've deliberately left out a specific "+X%" hydration claim until this is checked against the original paper.
What the evidence supports — and where it stops
SUPPORTED BY CURRENT HUMAN EVIDENCE
- Improved facial hydration and elasticity, measured directly
- Reduced periorbital wrinkles with continued use
- Peptide composition (Pro-Hyp/Hyp-Gly) drives efficacy more than collagen quantity
- Reduced UV-induced pigmentation (preliminary evidence)
- Reduced skin glycation (AGEs), with a correlated metabolic-aging signal
- Consistently well tolerated across all 5 trials
NOT YET SHOWN
- Effects beyond the 8–12 week windows tested in these trials
- Direct clinical testing of Japanese Targeted Collagen™ as a finished product
- A treatment effect on insulin resistance or any diagnosed metabolic condition
The through-line across all five trials is consistent: this is one of the more mechanistically well-characterised collagen ingredients available, precisely because the research asked which peptides matter, not just how much collagen to take.
Select references
- Sugihara F, Inoue N, Wang X. Clinical Effects of Ingesting Collagen Hydrolysate on Facial Skin Properties: A Randomized, Placebo-Controlled, Double-Blind Trial. Jpn Pharmacol Ther. 2015;43:67–70.
- Inoue N, Sugihara F, Wang X. Ingestion of Bioactive Collagen Hydrolysates Enhance Facial Skin Moisture and Elasticity and Reduce Facial Ageing Signs in a Randomised Double-Blind Placebo-Controlled Clinical Study. J Sci Food Agric. 2016;96:4077–4081.
- Koizumi S, Inoue N, Shimizu M, Kwon C-J, Kim H-Y, Park KS. Effects of Dietary Supplementation with Fish Scales-Derived Collagen Peptides on Skin Parameters and Condition: A Randomized, Placebo-Controlled, Double-Blind Study. Int J Pept Res Ther. 2017;24:397–402.
- Sugihara F, Inoue N. Clinical Effects of Collagen Hydrolysates Ingestion on UV-Induced Pigmented Spots of Human Skin: A Preliminary Study. Health Sci. 2012;28:153–156.
- Koizumi S, et al. Ingestion of a Collagen Peptide Containing High Concentrations of Prolyl-Hydroxyproline and Hydroxyprolyl-Glycine Reduces Advanced Glycation End Products Levels in the Skin and Subcutaneous Blood Vessel Walls: A Randomized, Double-Blind, Placebo-Controlled Study. Biosci Biotechnol Biochem. 2023.
Nitta Gelatin Inc.'s own "Wellnex® Bioactive Dipeptide Technology" technical dossier summarises these same five trials for B2B audiences. It's a legitimate manufacturer resource but not a distinct clinical study, so it isn't listed here as a separate reference — see the Dose Transparency section above.